Filter

Refine by Subjects

Refine by Access

Refine by Type

Refine by Date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 36 items for

  • Author or Editor: Evan M. Sisson x
  • All content x
Clear All Modify Search
Restricted access

Are Statins Safe to Use in Patients with Chronic Liver Disease?

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

Should All Patients with an Acute Coronary Event or at High CHD Risk Be Started on High-Dose Statin Therapy?

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

Table 1-8. Statin intensity

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

Fibric Acid Derivatives

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

Omega-3 Fatty Acids

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

Table 1-6: National Lipid Association Criteria for ASCVD Risk Assessment, Treatment Goals for Atherogenic Cholesterol, and Levels to Consider Drug Therapy

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

Table 1-10. Drugs that Can Lead to or Worsen Dyslipidemias

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

Table 1-2: Epidemiologic Data for Dyslipidemia

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

What Drug-Drug Interactions Impact Statin Therapy?

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014
Restricted access

Bile Acid Sequestrants

Edited by Evan M. Sisson, McKenzie Calhoun, and Michael A. Crouch

Chapter

Cover Dyslipidemia: Contemporary Evaluation and Management eReport

In  Dyslipidemia: Contemporary Evaluation and Management eReport

Published (Print):
Dec 2014